PTC Therapeutics Inc (PTCT)
40.86
+0.46
(+1.15%)
USD |
NASDAQ |
Nov 05, 16:00
40.86
0.00 (0.00%)
After-Hours: 18:22
PTC Therapeutics Cash from Investing (Quarterly): -65.92M for June 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -65.92M |
| March 31, 2024 | -114.93M |
| December 31, 2023 | -94.42M |
| September 30, 2023 | -29.60M |
| June 30, 2023 | -23.75M |
| March 31, 2023 | -28.97M |
| December 31, 2022 | 32.44M |
| September 30, 2022 | 136.44M |
| June 30, 2022 | 72.25M |
| March 31, 2022 | 49.04M |
| December 31, 2021 | 68.27M |
| September 30, 2021 | 64.70M |
| June 30, 2021 | 56.06M |
| March 31, 2021 | 30.15M |
| December 31, 2020 | -208.12M |
| September 30, 2020 | -394.21M |
| June 30, 2020 | 142.06M |
| March 31, 2020 | -101.27M |
| December 31, 2019 | -229.00M |
| September 30, 2019 | 30.43M |
| June 30, 2019 | -38.17M |
| March 31, 2019 | -150.50M |
| December 31, 2018 | -24.60M |
| September 30, 2018 | -24.11M |
| June 30, 2018 | 7.744M |
| Date | Value |
|---|---|
| March 31, 2018 | -1.648M |
| December 31, 2017 | -54.04M |
| September 30, 2017 | 19.27M |
| June 30, 2017 | 23.47M |
| March 31, 2017 | 24.42M |
| December 31, 2016 | 23.13M |
| September 30, 2016 | 38.24M |
| June 30, 2016 | 21.00M |
| March 31, 2016 | 22.12M |
| December 31, 2015 | -51.83M |
| September 30, 2015 | -6.284M |
| June 30, 2015 | 16.70M |
| March 31, 2015 | 20.61M |
| December 31, 2014 | -113.18M |
| September 30, 2014 | 48.38M |
| June 30, 2014 | -76.09M |
| March 31, 2014 | -4.267M |
| December 31, 2013 | 5.868M |
| September 30, 2013 | -122.02M |
| June 30, 2013 | -11.66M |
| March 31, 2013 | -0.021M |
| December 31, 2012 | -0.0055M |
| September 30, 2012 | -0.0043M |
| June 30, 2012 | -0.0208M |
| March 31, 2012 | -0.1584M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-394.21M
Minimum
Sep 2020
142.06M
Maximum
Jun 2020
-33.62M
Average
-23.75M
Median
Jun 2023
Cash from Investing (Quarterly) Benchmarks
| Pfizer Inc | 4.60B |
| Vertex Pharmaceuticals Inc | -463.70M |
| BridgeBio Pharma Inc | 3.039M |
| Cassava Sciences Inc | -0.029M |
| Crinetics Pharmaceuticals Inc | -53.64M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -71.45M |
| Cash from Financing (Quarterly) | 246.48M |
| Free Cash Flow | -230.14M |
| Free Cash Flow Per Share (Quarterly) | -0.8352 |
| Free Cash Flow to Equity (Quarterly) | -64.37M |
| Free Cash Flow to Firm (Quarterly) | -13.77M |
| Free Cash Flow Yield | -7.41% |